section name header

Pronunciation

me-CA-ser-min

Classifications

Therapeutic Classification: hormones

Pharmacologic Classification: growth hormones

Indications

REMS


Action

  • Under normal conditions, growth hormone attaches to receptors resulting in increased production of IGF-1. IGF-1 stimulates uptake of glucose, fatty acids and amino acids which support tissue growth. These processes signal and support statural growth.
Therapeutic effects:
  • Replacement of IGF-1 in deficiency states resulting in achievement of optimal potential statural growth.

Pharmacokinetics

Absorption: Well absorbed following SUBQ administration.

Distribution: Bound to various binding proteins.

Metabolism/Excretion: Some metabolism in liver and kidney.

Half-Life: 5.8 hr.

Time/Action Profile

(blood levels)

ROUTEONSETPEAKDURATION
SUBQrapid3 hr12 hr





Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Endo: HYPOGLYCEMIA

GI: vomiting

Local: bruising, lipohypertrophy

MS: arthralgia, extremity pain

Neuro: dizziness, headache, intracranial hypertension, SEIZURES

Resp: tonsillar hypertrophy, snoring

Misc: ANAPHYLAXIS, HYPERSENSITIVITY REACTIONS, MALIGNANCY, thymus hypertrophy

Interactions

Drug-drug:

Route/Dosage

Availability

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Increlex